TickerFacts.

Interpace Biosciences, Inc. (IDXG): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$38.73M
Year ended 2025-12-31
$36.14M
Trailing 12 months to 2026-06-30
+6.7%
3-year compound annual growth
$157.29M2010-12-31: $134.59M2011-12-31: $157.29M2012-12-31: $126.90M2013-12-31: $146.53M2014-12-31: $119.94M2015-12-31: $9.43M2016-12-31: $13.09M2017-12-31: $15.90M2018-12-31: $21.90M2019-12-31: $24.22M2020-12-31: $32.40M2021-12-31: $33.12M2022-12-31: $31.84M2023-12-31: $40.04M2024-12-31: $46.93M2025-12-31: $38.73M$38.73M
2010-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$38.73M-17.5%2026-03-30, From 2025-01-01
2024-12-31$46.93M+17.2%2026-03-30, From 2024-01-01
2023-12-31$40.04M+25.7%2025-03-31, From 2023-01-01
2022-12-31$31.84M-3.9%2024-04-01, From 2022-01-01
2021-12-31$33.12Mn/c2023-03-27, From 2021-01-01
2020-12-31$32.40M+33.8%2022-03-31, From 2020-01-01
2019-12-31$24.22M+10.6%2021-04-01, From 2019-01-01
2018-12-31$21.90M+37.7%2021-01-19, From 2018-01-01
2017-12-31$15.90M+21.5%2019-03-21, From 2017-01-01
2016-12-31$13.09M+38.7%2018-03-23, From 2016-01-01
2015-12-31$9.43M-92.1%2017-03-31, From 2015-01-01
2014-12-31$119.94M-18.2%2015-03-05, From 2014-01-01
2013-12-31$146.53M+15.5%2015-03-05, From 2013-01-01
2012-12-31$126.90M-19.3%2014-03-06, From 2012-01-01
2011-12-31$157.29M+16.9%2013-03-15, From 2011-01-01
2010-12-31$134.59Mn/a2012-03-09, From 2010-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Interpace Biosciences, Inc. (IDXG)2025-12-31$38.73M-17.5%
Utah Medical Products Inc (UTMD)2025-12-31$38.52M-5.8%
Retractable Technologies Inc (RVP)2025-12-31$38.27M+15.8%
Cytosorbents Corp (CTSO)2025-12-31$37.06M+4.1%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$36.97M+17.8%
KORU Medical Systems, Inc. (KRMD)2025-12-31$41.13M+22.2%
SS Innovations International, Inc. (SSII)2025-12-31$42.48M+105.7%
SANUWAVE Health, Inc. (SNWV)2025-12-31$44.05M+35.0%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$33.48Mn/m

Compare IDXG, UTMD, RVP, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗